Omidenepag isopropyl is a topical ocular hypotensive agent used to reduce intraocular pressure (IOP) in patients with glaucoma and ocular hypertension. Omidenepag isopropyl is quickly metabolized to its active metabolite, omidenepag, a molecule with high selectivity and agonistic activity towards the prostaglandin E2 (EP2) receptor. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Omlonti and Eybelis (TN). Its PubChem CID is 44230999.
Omidenepag isopropyl
| CAS No | 1187451-19-9 |
|---|---|
| Molecular Formula | C26H28N6O4S |
| Molecular Weight | 520.6 g/mol |
| Synonyms | propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Omidenepag isopropyl is a topical ocular hypotensive agent used to reduce intraocular pressure (IOP) in patients with glaucoma and ocular hypertension.
The listed CAS number is 1187451-19-9.
The listed molecular formula is C26H28N6O4S.
The listed molecular weight is 520.6 g/mol.
propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate.
The source lists Omlonti and Eybelis (TN).